VRDN Viridian Therapeutics | 6/29/2026 | Reiterated Rating | $17.90 | $32.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 6/17/2026 | Reiterated Rating | $75.21 | $102.00 | Buy | $0.00 00.00% ROI | |
HRTX Heron Therapeutics | 6/2/2026 | Downgrade | $0.45 | | Hold | $0.00 00.00% ROI | |
MANE Veradermics | 6/2/2026 | Initiated Coverage | $101.96 | $136.00 | Buy | $0.00 00.00% ROI | |
OCS Oculis | 6/1/2026 | Lower Price Target | $22.70 | $38.00 | Buy | $0.00 00.00% ROI | |
TRVI Trevi Therapeutics | 5/20/2026 | Reiterated Rating | $13.77 | $23.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 5/12/2026 | Boost Price Target | $18.84 | $30.00 | Buy | $0.00 00.00% ROI | |
OCS Oculis | 5/12/2026 | Boost Price Target | $30.40 | $46.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 5/11/2026 | Boost Price Target | $52.61 | $70.00 | Buy | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/8/2026 | Lower Price Target | $56.00 | $78.00 | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AMPH Amphastar Pharmaceuticals | 5/8/2026 | Reiterated Rating | $24.03 | | Hold | $0.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 5/7/2026 | Reiterated Rating | $24.17 | $36.00 | Buy | $0.00 00.00% ROI | |
TRVI Trevi Therapeutics | 5/6/2026 | Lower Price Target | $14.66 | $23.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2026 | Lower Price Target | $8.86 | $16.00 | Buy | $0.00 00.00% ROI | |
VRDN Viridian Therapeutics | 5/5/2026 | Reiterated Rating | $18.77 | $32.00 | Buy | $0.00 00.00% ROI | |
OCUL Ocular Therapeutix | 5/5/2026 | Reiterated Rating | $9.71 | $18.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 5/5/2026 | Boost Price Target | $77.20 | $102.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 5/4/2026 | Downgrade | $3.12 | | Hold | $0.00 00.00% ROI | |
PCRX Pacira BioSciences | 5/1/2026 | Boost Price Target | $25.49 | $32.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 4/30/2026 | Downgrade | $26.66 | | Hold | $0.00 00.00% ROI | |
CRMD CorMedix | 4/27/2026 | Boost Price Target | $7.54 | $15.00 | Buy | $0.00 00.00% ROI | |
VRDN Viridian Therapeutics | 3/30/2026 | Lower Price Target | $18.52 | $32.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 3/25/2026 | Boost Price Target | $17.14 | $36.00 | Buy | $0.00 00.00% ROI | |
COLL Collegium Pharmaceutical | 3/19/2026 | Reiterated Rating | $36.30 | $56.00 | Buy | $0.00 00.00% ROI | |
TRVI Trevi Therapeutics | 3/18/2026 | Boost Price Target | $11.19 | $24.00 | Buy | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 3/9/2026 | Boost Price Target | $61.46 | $80.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 3/5/2026 | Boost Price Target | $34.52 | $54.00 | Buy | $0.00 00.00% ROI | |
CRMD CorMedix | 3/5/2026 | Lower Price Target | $6.30 | $14.00 | Buy | $0.00 00.00% ROI | |
OCS Oculis | 3/4/2026 | Boost Price Target | $27.57 | $40.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/3/2026 | Boost Price Target | $2.94 | $5.00 | Buy | $0.00 00.00% ROI | |
AMPH Amphastar Pharmaceuticals | 2/27/2026 | Lower Price Target | $26.49 | $30.00 | Buy | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 2/27/2026 | Boost Price Target | $42.23 | $58.00 | Buy | $0.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 2/26/2026 | Boost Price Target | $27.01 | $36.00 | Buy | $0.00 00.00% ROI | |
COLL Collegium Pharmaceutical | 2/26/2026 | Lower Price Target | $44.01 | $54.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 2/25/2026 | Boost Price Target | $70.10 | $85.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 2/25/2026 | Reiterated Rating | $30.16 | $52.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/23/2026 | Boost Price Target | $18.68 | $25.00 | Buy | $0.00 00.00% ROI | |
OCUL Ocular Therapeutix | 2/20/2026 | Lower Price Target | $7.03 | $18.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 2/18/2026 | Boost Price Target | $36.41 | $48.00 | Buy | $0.00 00.00% ROI | |
VRDN Viridian Therapeutics | 2/4/2026 | Reiterated Rating | $31.90 | $42.00 | Buy | $0.00 00.00% ROI | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
ARQT Arcutis Biotherapeutics | 1/26/2026 | Boost Price Target | $26.29 | $31.00 | Buy | $0.00 00.00% ROI | |
PCRX Pacira BioSciences | 1/9/2026 | Reiterated Rating | $26.02 | $30.00 | Buy | $0.00 00.00% ROI | |
CRMD CorMedix | 1/8/2026 | Lower Price Target | $7.51 | $15.00 | Buy | $0.00 00.00% ROI | |
COLL Collegium Pharmaceutical | 1/8/2026 | Boost Price Target | $48.78 | $56.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 1/6/2026 | Boost Price Target | $15.66 | $32.00 | Buy | $0.00 00.00% ROI | |
EOLS Evolus | 12/24/2025 | Reiterated Rating | $6.81 | | Hold | $0.00 00.00% ROI | |
VRDN Viridian Therapeutics | 12/23/2025 | Boost Price Target | $32.47 | $42.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 12/22/2025 | Boost Price Target | $62.72 | $84.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 12/12/2025 | Reiterated Rating | $60.77 | $72.00 | Buy | $0.00 00.00% ROI | |
OCUL Ocular Therapeutix | 12/8/2025 | Reiterated Rating | $15.95 | $20.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 12/4/2025 | Reiterated Rating | $14.66 | $28.00 | Buy | $0.00 00.00% ROI | |
CLSD Clearside Biomedical | 11/18/2025 | Reiterated Rating | $3.32 | | Hold | $0.00 00.00% ROI | |
CRMD CorMedix | 11/12/2025 | Lower Price Target | $11.17 | $16.00 | Buy | $0.00 00.00% ROI | |
OCS Oculis | 11/11/2025 | Reiterated Rating | $19.42 | $36.00 | Buy | $0.00 00.00% ROI | |
AMPH Amphastar Pharmaceuticals | 11/7/2025 | Lower Price Target | $24.23 | $34.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 11/5/2025 | Boost Price Target | $39.84 | $46.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 11/4/2025 | Lower Price Target | $6.86 | $18.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 11/4/2025 | Boost Price Target | $25.22 | $52.00 | Buy | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 11/4/2025 | Reiterated Rating | $41.12 | $55.00 | Buy | $0.00 00.00% ROI | |
COLL Collegium Pharmaceutical | 10/28/2025 | Reiterated Rating | $34.81 | $46.00 | Buy | $0.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 10/28/2025 | Boost Price Target | $24.95 | $30.00 | Buy | $0.00 00.00% ROI | |
AMPH Amphastar Pharmaceuticals | 10/22/2025 | Reiterated Rating | $24.26 | $36.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 10/15/2025 | Boost Price Target | $6.42 | $20.00 | Buy | $0.00 00.00% ROI | |
OMER Omeros | 10/15/2025 | Reiterated Rating | $10.94 | | Hold | $0.00 00.00% ROI | |
OCUL Ocular Therapeutix | 10/1/2025 | Boost Price Target | $11.11 | $20.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 9/30/2025 | Lower Price Target | $6.24 | $20.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 9/12/2025 | Reiterated Rating | $13.60 | $28.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/2/2025 | Reiterated Rating | $35.33 | $72.00 | Buy | $0.00 00.00% ROI | |
OCS Oculis | 8/27/2025 | Initiated Coverage | $17.53 | $36.00 | Buy | $0.00 00.00% ROI | |
OMER Omeros | 8/15/2025 | Reiterated Rating | $4.12 | | Hold | $0.00 00.00% ROI | |
AMPH Amphastar Pharmaceuticals | 8/12/2025 | Upgrade | $27.36 | $36.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 8/12/2025 | Boost Price Target | $24.10 | $36.00 | Buy | $0.00 00.00% ROI | |
TRVI Trevi Therapeutics | 8/8/2025 | Lower Price Target | $7.30 | $22.00 | Buy | $0.00 00.00% ROI | |
HRTX Heron Therapeutics | 8/8/2025 | Lower Price Target | $1.33 | $3.00 | Buy | $0.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 8/7/2025 | Boost Price Target | $15.36 | $22.00 | Buy | $0.00 00.00% ROI | |
VRDN Viridian Therapeutics | 8/6/2025 | Lower Price Target | $17.22 | $34.00 | Buy | $0.00 00.00% ROI | |
EOLS Evolus | 8/6/2025 | Reiterated Rating | $8.91 | $22.00 | Hold | $0.00 00.00% ROI | |
OCUL Ocular Therapeutix | 8/5/2025 | Boost Price Target | $12.00 | $15.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 8/4/2025 | Reiterated Rating | $8.73 | $17.00 | Buy | $0.00 00.00% ROI | |
CLSD Clearside Biomedical | 7/17/2025 | Downgrade | $9.12 | $45.00 | Hold | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 6/25/2025 | Reiterated Rating | $9.78 | $17.00 | Buy | $00.00 00.00% ROI | |
CRMD CorMedix | 6/24/2025 | Boost Price Target | $16.56 | $20.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 6/12/2025 | Reiterated Rating | $20.50 | $40.00 | Buy | $00.00 00.00% ROI | |
LQDA Liquidia | 5/28/2025 | Reiterated Rating | $15.60 | $25.00 | Buy | $00.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 5/23/2025 | Reiterated Rating | $13.66 | $20.00 | Buy | $00.00 00.00% ROI | |
LQDA Liquidia | 5/21/2025 | Reiterated Rating | $17.02 | $25.00 | Buy | $00.00 00.00% ROI | |
TRVI Trevi Therapeutics | 5/20/2025 | Reiterated Rating | $6.49 | $24.00 | Buy | $00.00 00.00% ROI | |
VRDN Viridian Therapeutics | 5/20/2025 | Reiterated Rating | $13.25 | $36.00 | Buy | $00.00 00.00% ROI | |
OMER Omeros | 5/16/2025 | Reiterated Rating | $3.95 | | Hold | $00.00 00.00% ROI | |
CLSD Clearside Biomedical | 5/15/2025 | Lower Price Target | $12.81 | $45.00 | Buy | $0.00 00.00% ROI | |
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad) Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states.
The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. See which companies control the supply chain behind this emerging tech |
CYTK Cytokinetics | 5/14/2025 | Reiterated Rating | $30.61 | $72.00 | Buy | $00.00 00.00% ROI | |
VRCA Verrica Pharmaceuticals | 5/14/2025 | Reiterated Rating | $0.50 | | Hold | $0.00 00.00% ROI | |
XENE Xenon Pharmaceuticals | 5/13/2025 | Lower Price Target | $35.85 | $55.00 | Buy | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 5/13/2025 | Reiterated Rating | $40.18 | $66.00 | Buy | $00.00 00.00% ROI | |
LQDA Liquidia | 5/12/2025 | Reiterated Rating | $15.93 | $25.00 | Buy | $00.00 00.00% ROI | |
PCRX Pacira BioSciences | 5/9/2025 | Lower Price Target | $24.90 | $30.00 | Buy | $00.00 00.00% ROI | |
EOLS Evolus | 5/8/2025 | Reiterated Rating | $11.80 | $22.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 5/8/2025 | Lower Price Target | $19.50 | $40.00 | Buy | $00.00 00.00% ROI | |
VRDN Viridian Therapeutics | 5/7/2025 | Lower Price Target | $12.03 | $36.00 | Buy | $00.00 00.00% ROI | |
CRMD CorMedix | 5/7/2025 | Boost Price Target | $11.16 | $15.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 5/7/2025 | Lower Price Target | $0.98 | $4.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2025 | Boost Price Target | $11.03 | $17.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 5/2/2025 | Reiterated Rating | $42.92 | $72.00 | Buy | $00.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 4/30/2025 | Reiterated Rating | $40.18 | $66.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 4/25/2025 | Reiterated Rating | $0.88 | $5.00 | Buy | $0.00 00.00% ROI | |
HRTX Heron Therapeutics | 4/11/2025 | Reiterated Rating | $1.82 | $4.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 4/10/2025 | Reiterated Rating | $6.77 | $15.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 4/10/2025 | Reiterated Rating | $12.77 | $25.00 | Buy | $00.00 00.00% ROI | |
AMPH Amphastar Pharmaceuticals | 4/10/2025 | Reiterated Rating | $25.23 | | Hold | $00.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 4/9/2025 | Reiterated Rating | $13.29 | $20.00 | Buy | $00.00 00.00% ROI | |
VRCA Verrica Pharmaceuticals | 4/9/2025 | Reiterated Rating | $0.58 | | Hold | $0.00 00.00% ROI | |
EOLS Evolus | 4/9/2025 | Reiterated Rating | $9.36 | $22.00 | Buy | $0.00 00.00% ROI | |
CRMD CorMedix | 4/9/2025 | Reiterated Rating | $6.79 | $12.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 4/8/2025 | Reiterated Rating | $11.50 | $28.00 | Buy | $00.00 00.00% ROI | |
TRVI Trevi Therapeutics | 4/8/2025 | Reiterated Rating | $5.78 | $24.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 4/8/2025 | Reiterated Rating | $35.99 | $72.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 4/8/2025 | Reiterated Rating | $1.20 | $5.00 | Buy | $0.00 00.00% ROI | |
CLSD Clearside Biomedical | 4/8/2025 | Reiterated Rating | $12.68 | $60.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 4/8/2025 | Reiterated Rating | $15.86 | $42.00 | Buy | $00.00 00.00% ROI | |
PCRX Pacira BioSciences | 4/8/2025 | Reiterated Rating | $22.91 | $32.00 | Buy | $00.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 4/3/2025 | Reiterated Rating | $16.60 | $20.00 | Buy | $00.00 00.00% ROI | |
OMER Omeros | 4/1/2025 | Reiterated Rating | $8.27 | | Hold | $00.00 00.00% ROI | |
CLSD Clearside Biomedical | 3/28/2025 | Lower Price Target | $15.45 | $60.00 | Buy | $0.00 00.00% ROI | |
CRMD CorMedix | 3/26/2025 | Lower Price Target | $7.34 | $12.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 3/26/2025 | Reiterated Rating | $12.07 | $28.00 | Buy | $00.00 00.00% ROI | |
LQDA Liquidia | 3/20/2025 | Boost Price Target | $14.92 | $25.00 | Buy | $00.00 00.00% ROI | |
TRVI Trevi Therapeutics | 3/19/2025 | Lower Price Target | $6.56 | $24.00 | Buy | $00.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 3/13/2025 | Reiterated Rating | $12.45 | $28.00 | Buy | $00.00 00.00% ROI | |
OCUL Ocular Therapeutix | 3/11/2025 | Initiated Coverage | $7.65 | $15.00 | Buy | $0.00 00.00% ROI | |
TRVI Trevi Therapeutics | 3/10/2025 | Boost Price Target | $4.30 | $25.00 | Buy | $00.00 00.00% ROI | |
CLSD Clearside Biomedical | 3/6/2025 | Reiterated Rating | $14.40 | $90.00 | Buy | $0.00 00.00% ROI | |
EOLS Evolus | 3/5/2025 | Reiterated Rating | $14.35 | $22.00 | Buy | $0.00 00.00% ROI | |
PCRX Pacira BioSciences | 2/28/2025 | Boost Price Target | $25.38 | $32.00 | Buy | $00.00 00.00% ROI | |
HRTX Heron Therapeutics | 2/28/2025 | Reiterated Rating | $2.05 | $4.00 | Buy | $0.00 00.00% ROI | |
MLTX MoonLake Immunotherapeutics | 2/27/2025 | Boost Price Target | $42.37 | $66.00 | Buy | $00.00 00.00% ROI | |
ARQT Arcutis Biotherapeutics | 2/26/2025 | Reiterated Rating | $12.20 | $20.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 2/6/2025 | Reiterated Rating | $46.44 | $72.00 | Buy | $00.00 00.00% ROI | |
EOLS Evolus | 1/21/2025 | Reiterated Rating | $13.87 | $22.00 | Buy | $0.00 00.00% ROI | |
OMER Omeros | 1/17/2025 | Reiterated Rating | $9.18 | | Hold | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 1/13/2025 | Boost Price Target | $7.67 | $15.00 | Buy | $0.00 00.00% ROI | |
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War.
Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving.
Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today |
PCRX Pacira BioSciences | 1/13/2025 | Boost Price Target | $20.64 | $30.00 | Buy | $00.00 00.00% ROI | |